Foster BA - Search Results

1

In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.

Guo C, Yi H, Yu X, Zuo D, Qian J, Yang G, Foster BA, Subjeck JR, Sun X, Mikkelsen RB, Fisher PB, Wang XY. Guo C, et al. Among authors: foster ba. Mol Cancer Ther. 2012 Nov;11(11):2331-41. doi: 10.1158/1535-7163.MCT-12-0164. Epub 2012 Aug 15. Mol Cancer Ther. 2012. PMID: 22896667 Free PMC article.

2

Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24.

Gao P, Sun X, Chen X, Wang Y, Foster BA, Subjeck J, Fisher PB, Wang XY. Gao P, et al. Among authors: foster ba. Cancer Res. 2008 May 15;68(10):3890-8. doi: 10.1158/0008-5472.CAN-08-0156. Cancer Res. 2008. PMID: 18483274 Free PMC article.

3

The Thoc1 ribonucleoprotein and prostate cancer progression.

Chinnam M, Wang Y, Zhang X, Gold DL, Khoury T, Nikitin AY, Foster BA, Li Y, Bshara W, Morrison CD, Payne Ondracek RD, Mohler JL, Goodrich DW. Chinnam M, et al. Among authors: foster ba. J Natl Cancer Inst. 2014 Oct 8;106(11):dju306. doi: 10.1093/jnci/dju306. Print 2014 Nov. J Natl Cancer Inst. 2014. PMID: 25296641 Free PMC article.

4

Phenotype-specific CpG island methylation events in a murine model of prostate cancer.

Camoriano M, Kinney SR, Moser MT, Foster BA, Mohler JL, Trump DL, Karpf AR, Smiraglia DJ. Camoriano M, et al. Among authors: foster ba. Cancer Res. 2008 Jun 1;68(11):4173-82. doi: 10.1158/0008-5472.CAN-07-6715. Cancer Res. 2008. PMID: 18519676 Free PMC article.

5

Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.

Gelman IH, Peresie J, Eng KH, Foster BA. Gelman IH, et al. Among authors: foster ba. Mol Cancer Res. 2014 Oct;12(10):1470-9. doi: 10.1158/1541-7786.MCR-13-0490-T. Epub 2014 Jul 22. Mol Cancer Res. 2014. PMID: 25053806 Free PMC article.

6

The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.

Azrak RG, Frank CL, Ling X, Slocum HK, Li F, Foster BA, Rustum YM. Azrak RG, et al. Among authors: foster ba. Mol Cancer Ther. 2006 Oct;5(10):2540-8. doi: 10.1158/1535-7163.MCT-05-0546. Mol Cancer Ther. 2006. PMID: 17041098 Free PMC article.

7

Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.

Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Foster BA, et al. Cancer Res. 1997 Aug 15;57(16):3325-30. Cancer Res. 1997. PMID: 9269988

8

Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

Hurwitz AA, Foster BA, Kwon ED, Truong T, Choi EM, Greenberg NM, Burg MB, Allison JP. Hurwitz AA, et al. Among authors: foster ba. Cancer Res. 2000 May 1;60(9):2444-8. Cancer Res. 2000. PMID: 10811122

9

Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.

Bistulfi G, Foster BA, Karasik E, Gillard B, Miecznikowski J, Dhiman VK, Smiraglia DJ. Bistulfi G, et al. Among authors: foster ba. Cancer Prev Res (Phila). 2011 Nov;4(11):1825-34. doi: 10.1158/1940-6207.CAPR-11-0140. Epub 2011 Aug 11. Cancer Prev Res (Phila). 2011. PMID: 21836022 Free PMC article.

10

A transgenic mouse model for early prostate metastasis to lymph nodes.

Ko HK, Akakura S, Peresie J, Goodrich DW, Foster BA, Gelman IH. Ko HK, et al. Among authors: foster ba. Cancer Res. 2014 Feb 1;74(3):945-53. doi: 10.1158/0008-5472.CAN-13-1157. Cancer Res. 2014. PMID: 24492704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page